Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (Nasdaq: OACC) is a blank-check company sponsored by an affiliate of Oaktree Capital Management, L.P., the Los Angeles-based alternative investment manager with deep experience across credit and private equity. The vehicle targets acquisition opportunities in the life sciences sector, including biotechnology, pharmaceuticals, medical devices, and healthcare services. OACC completed its initial public offering in 2021 and remains an active reporting company, filing an 8-K with the Securities and Exchange Commission on October 17, 2025. The third SPAC in Oaktree's acquisition series, it reflects the firm's continued institutional focus on healthcare-oriented deal flow. Sign up for full data on SpacDesk to access OACC's complete filing history, deal status, and sponsor analytics.